ClinicalTrials HQ

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.

Recruiting · NCT05102747 · Registry updated 2026-01-27
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorderRecruitingNot applicable2026-01-27NCT05102747

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Association de Neuro-Oncologues d'Expression Francaise2
Centre Francois Baclesse35

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Antoine LacassagneNiceFrance60
Centre d'Oncologie et Radiothérapie Saint-JeanSaint-DoulchardFrance2
Centre Eugène MarquisRennesFrance37
Centre François BaclesseCaenFrance40
Centre Guillaume le ConquérantLe HavreFrance9
Centre Henri BecquerelRouenFrance71
Centre Hospitalier Lyon SudPierre-BéniteFrance14
CHUBrestFrance2
CHUGrenobleFrance2
CHUBordeauxFrance3
Groupe Hospitalier Bretagne SudLorientFrance6
Gustave RoussyVillejuifFrance47
Institut BergoniéBordeauxFrance47
Institut Claudius RegaudToulouseFrance13
La Pitié SalpétrièreParisFrance4